Global Anti-Infective Therapy Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Anti-Infective Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Penicillin
  • 1.2.3 Sulphonamides
  • 1.2.4 Aminoglycosides
  • 1.2.5 Fluoroquinolones
  • 1.2.6 Antifungals
  • 1.2.7 Antiprotozoal
  • 1.2.8 Others
• 1.3 Market by Application
  • 1.3.1 Global Anti-Infective Therapy Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Home User
  • 1.3.3 Hospitals/Clinics
  • 1.3.4 Ambulatory Surgery Centres
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Infective Therapy Market Perspective (2016-2027)
• 2.2 Anti-Infective Therapy Growth Trends by Regions
  • 2.2.1 Anti-Infective Therapy Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Anti-Infective Therapy Historic Market Share by Regions (2016-2021)
  • 2.2.3 Anti-Infective Therapy Forecasted Market Size by Regions (2022-2027)
• 2.3 Anti-Infective Therapy Industry Dynamic
  • 2.3.1 Anti-Infective Therapy Market Trends
  • 2.3.2 Anti-Infective Therapy Market Drivers
  • 2.3.3 Anti-Infective Therapy Market Challenges
  • 2.3.4 Anti-Infective Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Anti-Infective Therapy Players by Revenue
  • 3.1.1 Global Top Anti-Infective Therapy Players by Revenue (2016-2021)
  • 3.1.2 Global Anti-Infective Therapy Revenue Market Share by Players (2016-2021)
• 3.2 Global Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Anti-Infective Therapy Revenue
• 3.4 Global Anti-Infective Therapy Market Concentration Ratio
  • 3.4.1 Global Anti-Infective Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Therapy Revenue in 2020
• 3.5 Anti-Infective Therapy Key Players Head office and Area Served
• 3.6 Key Players Anti-Infective Therapy Product Solution and Service
• 3.7 Date of Enter into Anti-Infective Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Infective Therapy Breakdown Data by Type

• 4.1 Global Anti-Infective Therapy Historic Market Size by Type (2016-2021)
• 4.2 Global Anti-Infective Therapy Forecasted Market Size by Type (2022-2027)

5 Anti-Infective Therapy Breakdown Data by Application

• 5.1 Global Anti-Infective Therapy Historic Market Size by Application (2016-2021)
• 5.2 Global Anti-Infective Therapy Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Anti-Infective Therapy Market Size (2016-2027)
• 6.2 North America Anti-Infective Therapy Market Size by Type
  • 6.2.1 North America Anti-Infective Therapy Market Size by Type (2016-2021)
  • 6.2.2 North America Anti-Infective Therapy Market Size by Type (2022-2027)
  • 6.2.3 North America Anti-Infective Therapy Market Size by Type (2016-2027)
• 6.3 North America Anti-Infective Therapy Market Size by Application
  • 6.3.1 North America Anti-Infective Therapy Market Size by Application (2016-2021)
  • 6.3.2 North America Anti-Infective Therapy Market Size by Application (2022-2027)
  • 6.3.3 North America Anti-Infective Therapy Market Size by Application (2016-2027)
• 6.4 North America Anti-Infective Therapy Market Size by Country
  • 6.4.1 North America Anti-Infective Therapy Market Size by Country (2016-2021)
  • 6.4.2 North America Anti-Infective Therapy Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Anti-Infective Therapy Market Size (2016-2027)
• 7.2 Europe Anti-Infective Therapy Market Size by Type
  • 7.2.1 Europe Anti-Infective Therapy Market Size by Type (2016-2021)
  • 7.2.2 Europe Anti-Infective Therapy Market Size by Type (2022-2027)
  • 7.2.3 Europe Anti-Infective Therapy Market Size by Type (2016-2027)
• 7.3 Europe Anti-Infective Therapy Market Size by Application
  • 7.3.1 Europe Anti-Infective Therapy Market Size by Application (2016-2021)
  • 7.3.2 Europe Anti-Infective Therapy Market Size by Application (2022-2027)
  • 7.3.3 Europe Anti-Infective Therapy Market Size by Application (2016-2027)
• 7.4 Europe Anti-Infective Therapy Market Size by Country
  • 7.4.1 Europe Anti-Infective Therapy Market Size by Country (2016-2021)
  • 7.4.2 Europe Anti-Infective Therapy Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Anti-Infective Therapy Market Size (2016-2027)
• 8.2 Asia-Pacific Anti-Infective Therapy Market Size by Type
  • 8.2.1 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Anti-Infective Therapy Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Anti-Infective Therapy Market Size by Application
  • 8.3.1 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Anti-Infective Therapy Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Anti-Infective Therapy Market Size by Region
  • 8.4.1 Asia-Pacific Anti-Infective Therapy Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Anti-Infective Therapy Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Anti-Infective Therapy Market Size (2016-2027)
• 9.2 Latin America Anti-Infective Therapy Market Size by Type
  • 9.2.1 Latin America Anti-Infective Therapy Market Size by Type (2016-2021)
  • 9.2.2 Latin America Anti-Infective Therapy Market Size by Type (2022-2027)
  • 9.2.3 Latin America Anti-Infective Therapy Market Size by Type (2016-2027)
• 9.3 Latin America Anti-Infective Therapy Market Size by Application
  • 9.3.1 Latin America Anti-Infective Therapy Market Size by Application (2016-2021)
  • 9.3.2 Latin America Anti-Infective Therapy Market Size by Application (2022-2027)
  • 9.3.3 Latin America Anti-Infective Therapy Market Size by Application (2016-2027)
• 9.4 Latin America Anti-Infective Therapy Market Size by Country
  • 9.4.1 Latin America Anti-Infective Therapy Market Size by Country (2016-2021)
  • 9.4.2 Latin America Anti-Infective Therapy Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Anti-Infective Therapy Market Size (2016-2027)
• 10.2 Middle East & Africa Anti-Infective Therapy Market Size by Type
  • 10.2.1 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Anti-Infective Therapy Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Anti-Infective Therapy Market Size by Application
  • 10.3.1 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Anti-Infective Therapy Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Anti-Infective Therapy Market Size by Country
  • 10.4.1 Middle East & Africa Anti-Infective Therapy Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Anti-Infective Therapy Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abbott Laboratories Ltd.
  • 11.1.1 Abbott Laboratories Ltd. Company Details
  • 11.1.2 Abbott Laboratories Ltd. Business Overview
  • 11.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Introduction
  • 11.1.4 Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.1.5 Abbott Laboratories Ltd. Recent Development
• 11.2 Cipla Ltd.
  • 11.2.1 Cipla Ltd. Company Details
  • 11.2.2 Cipla Ltd. Business Overview
  • 11.2.3 Cipla Ltd. Anti-Infective Therapy Introduction
  • 11.2.4 Cipla Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.2.5 Cipla Ltd. Recent Development
• 11.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
  • 11.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
  • 11.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
  • 11.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Introduction
  • 11.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
• 11.4 Glenmark Pharmaceuticals Limited
  • 11.4.1 Glenmark Pharmaceuticals Limited Company Details
  • 11.4.2 Glenmark Pharmaceuticals Limited Business Overview
  • 11.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Introduction
  • 11.4.4 Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.4.5 Glenmark Pharmaceuticals Limited Recent Development
• 11.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
  • 11.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
  • 11.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
  • 11.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Introduction
  • 11.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
• 11.6 Lupin Limited
  • 11.6.1 Lupin Limited Company Details
  • 11.6.2 Lupin Limited Business Overview
  • 11.6.3 Lupin Limited Anti-Infective Therapy Introduction
  • 11.6.4 Lupin Limited Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.6.5 Lupin Limited Recent Development
• 11.7 Panacea Biotec Limited
  • 11.7.1 Panacea Biotec Limited Company Details
  • 11.7.2 Panacea Biotec Limited Business Overview
  • 11.7.3 Panacea Biotec Limited Anti-Infective Therapy Introduction
  • 11.7.4 Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.7.5 Panacea Biotec Limited Recent Development
• 11.8 Novartis AG
  • 11.8.1 Novartis AG Company Details
  • 11.8.2 Novartis AG Business Overview
  • 11.8.3 Novartis AG Anti-Infective Therapy Introduction
  • 11.8.4 Novartis AG Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.8.5 Novartis AG Recent Development
• 11.9 Pfizer, Inc.
  • 11.9.1 Pfizer, Inc. Company Details
  • 11.9.2 Pfizer, Inc. Business Overview
  • 11.9.3 Pfizer, Inc. Anti-Infective Therapy Introduction
  • 11.9.4 Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.9.5 Pfizer, Inc. Recent Development
• 11.10 Ranbaxy Laboratories Limited
  • 11.10.1 Ranbaxy Laboratories Limited Company Details
  • 11.10.2 Ranbaxy Laboratories Limited Business Overview
  • 11.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Introduction
  • 11.10.4 Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.10.5 Ranbaxy Laboratories Limited Recent Development
• 11.11 Sun Pharmaceutical Industries Limited
  • 11.11.1 Sun Pharmaceutical Industries Limited Company Details
  • 11.11.2 Sun Pharmaceutical Industries Limited Business Overview
  • 11.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Introduction
  • 11.11.4 Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.11.5 Sun Pharmaceutical Industries Limited Recent Development
• 11.12 AstraZeneca plc
  • 11.12.1 AstraZeneca plc Company Details
  • 11.12.2 AstraZeneca plc Business Overview
  • 11.12.3 AstraZeneca plc Anti-Infective Therapy Introduction
  • 11.12.4 AstraZeneca plc Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.12.5 AstraZeneca plc Recent Development
• 11.13 Johnson & Johnson
  • 11.13.1 Johnson & Johnson Company Details
  • 11.13.2 Johnson & Johnson Business Overview
  • 11.13.3 Johnson & Johnson Anti-Infective Therapy Introduction
  • 11.13.4 Johnson & Johnson Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.13.5 Johnson & Johnson Recent Development
• 11.14 WOCKHARDT
  • 11.14.1 WOCKHARDT Company Details
  • 11.14.2 WOCKHARDT Business Overview
  • 11.14.3 WOCKHARDT Anti-Infective Therapy Introduction
  • 11.14.4 WOCKHARDT Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.14.5 WOCKHARDT Recent Development
• 11.15 F. Hoffmann-La Roche Ltd
  • 11.15.1 F. Hoffmann-La Roche Ltd Company Details
  • 11.15.2 F. Hoffmann-La Roche Ltd Business Overview
  • 11.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Introduction
  • 11.15.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.15.5 F. Hoffmann-La Roche Ltd Recent Development
• 11.16 Sanofi
  • 11.16.1 Sanofi Company Details
  • 11.16.2 Sanofi Business Overview
  • 11.16.3 Sanofi Anti-Infective Therapy Introduction
  • 11.16.4 Sanofi Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.16.5 Sanofi Recent Development
• 11.17 Merck
  • 11.17.1 Merck Company Details
  • 11.17.2 Merck Business Overview
  • 11.17.3 Merck Anti-Infective Therapy Introduction
  • 11.17.4 Merck Revenue in Anti-Infective Therapy Business (2016-2021)
  • 11.17.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer